<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: AstraZeneca receives EU approval for new lung cancer treatment	</title>
	<atom:link href="https://ukinvestor.foxrobinson.com/astrazeneca-receives-eu-approval-for-new-lung-cancer-treatment/feed/" rel="self" type="application/rss+xml" />
	<link>https://ukinvestor.foxrobinson.com/astrazeneca-receives-eu-approval-for-new-lung-cancer-treatment/</link>
	<description></description>
	<lastBuildDate>Mon, 19 Oct 2020 13:01:15 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.6.3</generator>
	<item>
		<title>
		By: Midatech Pharma MTX110 could double rare brain tumour survival beyond a year - UK Investor Magazine		</title>
		<link>https://ukinvestor.foxrobinson.com/astrazeneca-receives-eu-approval-for-new-lung-cancer-treatment/#comment-16123</link>

		<dc:creator><![CDATA[Midatech Pharma MTX110 could double rare brain tumour survival beyond a year - UK Investor Magazine]]></dc:creator>
		<pubDate>Mon, 19 Oct 2020 13:01:15 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestor.foxrobinson.com/?p=30715#comment-16123</guid>

					<description><![CDATA[[&#8230;] is a primary brain tumour arising in the middle of the brain stem, and cannot be surgically removed. This particular tumour [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] is a primary brain tumour arising in the middle of the brain stem, and cannot be surgically removed. This particular tumour [&#8230;]</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: AstraZeneca shares slip as vaccine trial put on hold - UK Investor Magazine		</title>
		<link>https://ukinvestor.foxrobinson.com/astrazeneca-receives-eu-approval-for-new-lung-cancer-treatment/#comment-15888</link>

		<dc:creator><![CDATA[AstraZeneca shares slip as vaccine trial put on hold - UK Investor Magazine]]></dc:creator>
		<pubDate>Wed, 09 Sep 2020 12:27:44 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestor.foxrobinson.com/?p=30715#comment-15888</guid>

					<description><![CDATA[[&#8230;] at Cambridge-based pharmaceutical firm AstraZeneca (LON:AZN) have slipped 1.55% as its coronavirus vaccine trial is put on hold after a participant [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] at Cambridge-based pharmaceutical firm AstraZeneca (LON:AZN) have slipped 1.55% as its coronavirus vaccine trial is put on hold after a participant [&#8230;]</p>
]]></content:encoded>
		
			</item>
	</channel>
</rss>
